Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;35(4):360-367.
doi: 10.1097/HCO.0000000000000758.

Review - current opinion in cardiology hypertension in chronic kidney disease

Muhannad Alqudsi  1   2 , Swapnil Hiremath  3 , Juan Carlos Q Velez  1   2
Affiliations

Review - current opinion in cardiology hypertension in chronic kidney disease

Muhannad Alqudsi et al. Curr Opin Cardiol. 2020 Jul.

Abstract

Purpose of review: Hypertension is a major risk factor for cardiovascular disease, cerebrovascular events, and progression to end-stage kidney disease (ESKD). The kidneys play a causative role in hypertension, but they are also organs vulnerable to hypertensive injury. Thus far, goals for optimal blood pressure in chronic kidney disease (CKD) and ESKD patients are not fully elucidated. Herein, we critically review the existing evidence.

Recent findings: Large randomized controlled trials (RCTs) continue to be deemed as the best source of evidence to guide optimal blood pressure goals in CKD and ESKD patients. Despite recent advances, the growing body of literature does not permit drawing definitive conclusions. Few adequately powered RCTs have specifically assessed goals for treatment of hypertension in patients with CKD. The most recent large RCT in hypertension, the Systolic Blood Pressure Intervention Trial, included a subset of patients with CKD and provided some insights. For the ESKD population, trials to evaluate blood pressure goals are even more scarce. The Blood Pressure in Dialysis Trial was a relatively small pilot study that can be deemed as hypothesis generating.

Summary: Management of hypertension in CKD is essential for optimization of cardiovascular, cerebrovascular and renal outcomes. To date, the existing evidence does not fully clarify ideal targets for blood pressure control in this patient population.

PubMed Disclaimer

References

    1. Thomas G. Hypertension management in chronic kidney disease and diabetes. Cardiol Clin 2019; 37:307–317.
    1. Rossignol P, Massy ZA, Azizi M, Bakris G. The double challenge of resistant hypertension and chronic kidney disease. Lancet 2015; 386:1588–1598.
    1. Udani S, Lazich I, Bakris G. Epidemiology of hypertensive kidney disease. Nat Rev Nephrol 2011; 7:11–21.
    1. Crowley SD, Coffman TM. The inextricable role of the kidney in hypertension. J Clin Invest 2014; 124:2341–2347.
    1. Limou S, Nelson GW, Kopp JB, Winkler CA. APOL1 kidney risk alleles: population genetics and disease associations. Adv Chron Kidney Dis 2014; 21:426–433.